Oxcarbazepine XR
804P302
Phase 3 small_molecule completed
Quick answer
Oxcarbazepine XR for Partial Epilepsy is a Phase 3 program (small_molecule) at SUPERNUS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SUPERNUS PHARMACEUTICALS, INC.
- Indication
- Partial Epilepsy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed